Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apatinib in Combination With SBRT Treatment for Symptomatic Metastatic

NCT02998242 is registered in ClinicalTrials.gov with Sichuan Provincial People's Hospital as lead sponsor.

NCT NCT02998242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02998242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apatinib in Combination With SBRT Treatment for Symptomatic Metastatic
Lead sponsor
Sichuan Provincial People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 10, 2016
Completion date
December 10, 2017
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

quality of life